참고문헌
- Abdelnour-Berchtold E, Cerantola Y, Roulin D, et al (2010). Rapamycin-mediated FOXO1 inactivation reduces the anticancer efficacy of rapamycin. Anticancer Res, 30, 799-804.
- Ando T, Kawabe T, Ohara H, et al (2001). Involvement of the interaction between p21 and proliferating cell nuclear antigen for the maintenance of G2/M arrest after DNA damage. J Biol Chem, 276, 42971-7. https://doi.org/10.1074/jbc.M106460200
- Asano J, Chiba K, Tada M, et al (1996). Cytotoxic xanthones from Garcinia hanburyi. Phytoch mistry, 41, 815-20. https://doi.org/10.1016/0031-9422(95)00682-6
- Dudek AZ, Zolnierek J, Dham A, et al (2009). Sequential therapy with sorafenib and sunitinib in renal cell carcinoma. Cancer, 115, 61-7. https://doi.org/10.1002/cncr.24009
- Feldman DR, Baum MS, Ginsberg MS, et al (2009). Phase I trial of bevacizumab plus escalated doses of sunitinib in patients with metastatic renal cell carcinoma. J Clin Oncol, 27, 1432-9. https://doi.org/10.1200/JCO.2008.19.0108
- Gary H, Michael C, Piotr T, et al (2007). Temsirolimus, Interferon Alfa,or Both for Advanced Renal-Cell Carcinoma. N Engl J Med, 356, 2271-81. https://doi.org/10.1056/NEJMoa066838
- Gu H, Rao S, Zhao J, et al (2009). Gambogic acid reduced bcl-2 expression via p53 in human breast MCF-7 cancer cells. J Cancer Res Clin Oncol, 135, 1777-82. https://doi.org/10.1007/s00432-009-0624-2
- Iwata H, Sato H, Suzuki R, et al (2011). A demethylating agent enhances chemosensitivity to vinblastine in a xenograft model of renal cell carcinoma. Int J Oncol, 38, 1653-61.
- Jemal A, Siegel R, Ward E, et al (2009). Cancer statistics, 2009. CA Cancer J Clin, 59, 225-49. https://doi.org/10.3322/caac.20006
- Kausch I, Jiang H, Thode B, et al (2005). Inhibition of bcl-2 enhances the efficacy of chemotherapy in renal cell carcinoma. Eur Urol, 47, 703-9. https://doi.org/10.1016/j.eururo.2004.11.013
- Li C, Lu N, Qi Q, et al (2011). Gambogic acid inhibits tumor cell adhesion by suppressing integrin beta1 and membrane lipid rafts-associated integrin signaling pathway. Biochem Pharmacol, 82, 1873-83. https://doi.org/10.1016/j.bcp.2011.09.013
- Lu L, Tang D, Wang L, et al (2012). Gambogic acid inhibits TNF-alpha-induced invasion of human prostate cancer PC3 cells in vitro through PI3K/Akt and NF-kappaB signaling pathways. Acta Pharmacol Sin, 33, 531-41. https://doi.org/10.1038/aps.2011.180
- Lu N, Yang Y, You Q D, et al (2007). Gambogic acid inhibits angiogenesis through suppressing vascular endothelial growth factor-induced tyrosine phosphorylation of KDR/ Flk-1. Cancer Lett, 258, 80-9. https://doi.org/10.1016/j.canlet.2007.08.015
- Medema RH, Klompmaker R, Smits VA, Rijksen G (1998). p21waf1 can block cells at two points in the cell cycle, but does not interfere with processive DNA-replication or stressactivated kinases. Oncogene, 16, 431 -41. https://doi.org/10.1038/sj.onc.1201558
- Merseburger AS, Kuczyk MA (2008). Value of targeted therapies for renal cell cancer. Urologe, 47, 1303-10. https://doi.org/10.1007/s00120-008-1746-x
- Miyake M, Anai S, Fujimoto K, et al (2012). 5-fluorouracil enhances the antitumor effect of sorafenib and sunitinib in a xenograft model of human renal cell carcinoma. Oncol Lett, 3, 1195-202.
- Motzer RJ, Hudes GR, Ginsberg MS, et al (2010). Phase I/II trial of sunitinib plus gefitinib in patients with metastatic renal cell carcinoma. Am J Clin Oncol, 33, 614-8. https://doi.org/10.1097/COC.0b013e3181c4454d
- Motzer RJ, Michaelson MD, Redman BG, et al (2006a). Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma. J Clin Oncol, 24, 16-24. https://doi.org/10.1200/JCO.2005.02.2574
- Motzer RJ, Rini BI, Bukowski RM, et al (2006b). Sunitinib in patients with metastatic renal cell carcinoma. JAMA, 295, 2516-24. https://doi.org/10.1001/jama.295.21.2516
- Pandey MK, Sung B, Ahn KS, et al (2007). Gambogic acid, a novel ligand for transferrin receptor, potentiates TNFinduced apoptosis through modulation of the nuclear factorkappaB signaling pathway. Blood, 110, 3517-25. https://doi.org/10.1182/blood-2007-03-079616
- Qi Q, Gu H, Yang Y, et al (2008). Involvement of matrix metalloproteinase 2 and 9 in gambogic acid induced suppression of MDA-MB-435 human breast carcinoma cell lung metastasis. J Mol Med (Berl), 86, 1367-77. https://doi.org/10.1007/s00109-008-0398-z
- Rini BI, Atkins MB (2009). Resistance to targeted therapy in renal-cell carcinoma. Lancet Oncol, 10, 992-1000. https://doi.org/10.1016/S1470-2045(09)70240-2
- Rong JJ, Hu R, Qi Q, et al (2009). Gambogic acid down-regulates MDM2 oncogene and induces p21(Waf1/CIP1) expression independent of p53. Cancer Lett, 284, 102-12. https://doi.org/10.1016/j.canlet.2009.04.011
- Saito Y, Tanaka Y, Aita Y, et al (2012). Sunitinib induces apoptosis in pheochromocytoma tumor cells by inhibiting VEGFR2/Akt/mTOR/S6K1 pathways through modulation of Bcl-2 and BAD. Am J Physiol Endocrinol Metab, 302, E615-25. https://doi.org/10.1152/ajpendo.00035.2011
- Uetsuka H, Haisa M, Kimura M, et al (2003). Inhibition of inducible NF-kappaB activity reduces chemoresistance to 5-fluorouracil in human stomach cancer cell line. Exp Cell Res, 289, 27-35. https://doi.org/10.1016/S0014-4827(03)00223-4
- Wang J, Liu W, Zhao Q, et al (2009). Synergistic effect of 5-fluorouracil with gambogic acid on BGC-823 human gastric carcinoma. Toxicology, 256, 135-40. https://doi.org/10.1016/j.tox.2008.11.014
- Wang T, Wei J, Qian X, et al (2008). Gambogic acid, a potent inhibitor of survivin, reverses docetaxel resistance in gastric cancer cells. Cancer Lett, 262, 214-22. https://doi.org/10.1016/j.canlet.2007.12.004
- Yu J, Guo QL, You QD, et al (2007). Gambogic acid-induced G2/M phase cell-cycle arrest via disturbing CDK7-mediated phosphorylation of CDC2/p34 in human gastric carcinoma BGC-823 cells. Carcinogenesis, 28, 632-8.
- Zhang L, Yi Y, Chen J, et al (2010). Gambogic acid inhibits Hsp90 and deregulates TNF-alpha/NF-kappaB in HeLa cells. Biochem Biophys Res Commun, 403, 282-7. https://doi.org/10.1016/j.bbrc.2010.11.018
피인용 문헌
- Recent Research on Bioactive Xanthones from Natural Medicine: Garcinia hanburyi vol.16, pp.4, 2015, https://doi.org/10.1208/s12249-015-0339-4
- Hispidulin Potentiates the Antitumor Effect of Sunitinib Against Human Renal Cell Carcinoma in Laboratory Models vol.71, pp.2, 2015, https://doi.org/10.1007/s12013-014-0260-6
- In�vitro�and�in�vivo targeting of bladder carcinoma with metformin in combination with cisplatin pp.1792-1082, 2015, https://doi.org/10.3892/ol.2015.3267
- UNC119 mediates gambogic acid-induced cell-cycle dysregulation through the Gsk3β/β-catenin pathway in hepatocellular carcinoma cells vol.27, pp.10, 2016, https://doi.org/10.1097/CAD.0000000000000416
- Molecular targets of gambogic acid in cancer: recent trends and advancements vol.37, pp.10, 2016, https://doi.org/10.1007/s13277-016-5194-8